AVROBIO CSO Christopher Mason to depart June 30; option exercise period extended to 12 months

Tectonic Therapeutic, Inc.

Chief Scientific Officer Christopher Mason's employment ends June 30, 2022 per prior agreement.
Compensation committee extended post-termination exercise period for his time-based stock options and equity awards from 3 to 12 months.
Company also updated its corporate slide presentation for investor meetings; no new specific data disclosed.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christopher Mason

Chief Scientific Officer

TECX · Tectonic Therapeutic, Inc.

Effective: 2022-06-30
Filed: June 29, 2022, 7:59 PM ET

As previously disclosed, Dr. Mason’s employment with the Company will terminate on June 30, 2022 pursuant to the terms of his employment agreement, as amended.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Mason was terminated as Chief Scientific Officer at Tectonic Therapeutic, Inc..

Action: terminated
Role: Chief Scientific Officer

Exact text from the filing

As previously disclosed, Dr. Mason’s employment with the Company will terminate on June 30, 2022 pursuant to the terms of his employment agreement, as amended.

View on SEC.gov

Tectonic Therapeutic, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-185087

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.